Singapore: Edwards Lifesciences, the global leader in the science of heart valves and hemodynamic monitoring, received ...
Singapore: Type 2 diabetes treatment market in Asia-Pacific (APAC) will rise in value from an estimated $6.5 billion in ...
Singapore: However, companies must reinvigorate and expand their deal-making strategies in order to become market leade...
Singapore: Morgan Stanley Private Equity Asia (MSPEA) recently announced its partnership with HongKong listed Sihuan Pha...
Singapore: 3SBio received a preliminary non-binding proposal letter dated September 12, 2012, from its chairman and CEO...
Singapore: Mr Mark Reilly, the former head of British drug maker GlaxoSmithKline, who has been at the center of the brib...
Singapore: A shocking revelation, by the quality control manager at Husi Food, China indicated that expired meat was reu...
‎Singapore: Tianyin Pharmaceutical (TPI), China-based pharmaceutical company that specializes in patented biopharm...
Singapore: China's Yisheng Biopharma, a biopharmaceutical company developing vaccines, has developed a new vaccine for t...
‎Singapore: WuXi PharmaTech, a leading contract research organization with operations in China US, and PRA have si...
Singapore: Taiwan is striving to elevate its biotechnology and medicine industry with a combined support from both the p...
With a population of over 1.3 billion, China is poised for continued growth in the life sciences sector. There are sever...
Singapore: China's State Intellectual Property Office (SIPO) has yanked the patent for Gilead Sciences popular HIV and h...
Singapore: Innovent Biologics, a company dedicated to the development and manufacturing of monoclonal antibodies, is con...
Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry has a...
Singapore: Gene expression profiling can bring significant improvements to disease profiling and diagnoses based on gene...
Singapore: The National Health and Family Planning Commission of China has notified WHO of an additional 10 laboratory-...
DelMar Pharmaceuticals was founded in 2010 to rapidly develop and commercialize proven cancer therapies in new indicatio...
